Inventor · disambiguated record
Yeon-Hee Lim
Also filed as: LIM YEON-HEE
20 granted patents·7 pending applications·44 citations·filing 2008–2025
91Inventor score
Files withMERCK SHARP & DOHME12MERCK SHARP & DOHME LLC11ANTHES JOHN C1BOYCE CHRISTOPHER W1PURAKKATTLE BIJU J1
Top patents by PatentIndex Score
27 records- 0186US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0285US11787810B2Diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 17, 2023·2 cites·13 claims
- 0384US8524697B2C20-C21 substituted glucocorticoid receptor agonistsANTHES JOHN C·Filed 2008·Granted Sep 3, 2013·20 cites·7 claims
- 0483US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 0581US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 0679US9708347B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·3 cites·15 claims
- 0777US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 0875US12428411B2Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Granted Sep 30, 2025·0 cites·26 claims
- 0975US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 1073US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 1172US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1269US12448384B2Diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Granted Oct 21, 2025·0 cites·29 claims
- 1369US10344039B2Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their useMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·17 claims
- 1469US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 1564US12410159B2Preparation of oxindole derivatives as novel diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 9, 2025·0 cites·48 claims
- 1661US12414952B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 1760US12466831B2Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Nov 11, 2025·0 cites·14 claims
- 1859US2025171447A1Adenosine receptor antagonists, pharmaceutical compositions and their use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1958US2024254114A1Preparation of fused azole derivatives as novel diacylglyceride 0-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2055US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 2153US2023322785A1Adenosine a2a and a2b receptor dual antagonists for immuno-oncologyBOYCE CHRISTOPHER W·Filed 2022·Application pending·0 cites
- 2251US11976061B2Preparation of benzimidazolone derivatives as novel diacylglyceride O-acyltransferase 2 inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted May 7, 2024·0 cites·39 claims
- 2347US11498923B2Substituted imidazo[1,2-c]quinazolines as A2A antagonistsMERCK SHARP & DOHME·Filed 2018·Granted Nov 15, 2022·0 cites·5 claims
- 2447US2011262368A1C21 thioethers as glucocorticoid receptor agonistsSCHERING CORP·Filed 2008·Application pending·0 cites
- 2543US11046714B22,2-difluorodioxolo A2A receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jun 29, 2021·0 cites·14 claims
- 2638US10214512B2Factor XIA inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·0 cites·14 claims
- 2733US2012171126A1NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOFPURAKKATTLE BIJU J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yeon-Hee Lim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →